{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:38:28Z","timestamp":1791902308661,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institutes on Drug Abuse","doi-asserted-by":"crossref","award":["5R01DA003574"],"award-info":[{"award-number":["5R01DA003574"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10461-025-04732-9","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T10:00:15Z","timestamp":1745488815000},"page":"2748-2757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Heroin, Fentanyl, Intentional Fentanyl Use and HIV Transmission in a Community-Recruited Sample of Persons Who Inject Drugs, New York City: 2021\u20132023"],"prefix":"10.1007","volume":"29","author":[{"given":"Don C.","family":"Des Jarlais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenziheng Allen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Feelemyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Khezri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marley","family":"Reynoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Uuskula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"2","key":"4732_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1525-1381.1999.09248.x","volume":"111","author":"DC Des Jarlais","year":"1999","unstructured":"Des Jarlais DC, Hubbard R. Treatment for drug dependence. Proc Assoc Am Phys. 1999;111(2):126\u201330.","journal-title":"Proc Assoc Am Phys."},{"key":"4732_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010. Epub 20190202.","journal-title":"Int J Drug Policy"},{"issue":"12","key":"4732_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2021.1169","volume":"325","author":"GT Baldwin","year":"2021","unstructured":"Baldwin GT, Seth P, Noonan RK. Continued increases in overdose deaths related to synthetic opioids: implications for clinical practice. JAMA. 2021;325(12):1151\u20132.","journal-title":"JAMA"},{"key":"4732_CR4","doi-asserted-by":"crossref","unstructured":"Kariisa M. Illicitly manufactured fentanyl\u2013involved overdose deaths with detected xylazine\u2014United States, January 2019\u2013June 2022. MMWR Morbidity and mortality weekly report. 2023;72.","DOI":"10.15585\/mmwr.mm7226a4"},{"issue":"1","key":"4732_CR5","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/08897077.2021.1946892","volume":"43","author":"S Ickowicz","year":"2022","unstructured":"Ickowicz S, Kerr T, Grant C, Milloy M-J, Wood E, Hayashi K. Increasing preference for Fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017\u20132018. Substance Abuse. 2022;43(1):458\u201364. PubMed PMID: 34283705.","journal-title":"Substance Abuse"},{"key":"4732_CR6","doi-asserted-by":"crossref","unstructured":"Bazazi AR, Low P, Gomez BO, Snyder H, Hom JK, Soran CS et al. Overdose from unintentional Fentanyl use when intending to use a non-opioid substance: an analysis of medically attended opioid overdose events. J Urb Health. 2024;101(2):245\u201351.","DOI":"10.1007\/s11524-024-00852-0"},{"key":"4732_CR7","doi-asserted-by":"crossref","unstructured":"McKnight C, Weng CA, Reynoso M, Kimball S, Thompson LM, Des Jarlais DC. Understanding intentionality of Fentanyl use and drug overdose risk: findings from a mixed methods study of people who inject drugs in New York City. Int J Drug Policy. 2023;118:104063.","DOI":"10.1016\/j.drugpo.2023.104063"},{"key":"4732_CR8","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of Fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661.","journal-title":"Int J Drug Policy"},{"key":"4732_CR9","doi-asserted-by":"publisher","first-page":"104086","DOI":"10.1016\/j.drugpo.2023.104086","volume":"118","author":"K Bailey","year":"2023","unstructured":"Bailey K, Abramovitz D, Artamonova I, Davidson P, Stamos-Buesig T, Vera CF, et al. Drug checking in the Fentanyl era: utilization and interest among people who inject drugs in San Diego, California. Int J Drug Policy. 2023;118:104086.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"4732_CR10","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jamainternmed.2021.4109","volume":"181","author":"MA Incze","year":"2021","unstructured":"Incze MA. Reassessing the role of routine urine drug screening in opioid use disorder treatment. JAMA Intern Med. 2021;181(10):1282\u20133.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"4732_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ajad.13092","volume":"30","author":"S Martinez","year":"2021","unstructured":"Martinez S, Jones JD, Brandt L, Campbell AN, Abbott R, Comer SD. The increasing prevalence of Fentanyl: a urinalysis-based study among individuals with opioid use disorder in new York City. Am J Addictions. 2021;30(1):65\u201371.","journal-title":"Am J Addictions"},{"issue":"14","key":"4732_CR12","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1007\/s11606-022-07471-y","volume":"37","author":"D Qi","year":"2022","unstructured":"Qi D, Abri K, Mukherjee MR, Rosenwohl-Mack A, Khoeur L, Barnard L, et al. Health impact of street sweeps from the perspective of healthcare providers. J Gen Intern Med. 2022;37(14):3707\u201314.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"4732_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"issue":"6","key":"4732_CR14","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/S2352-3018(20)30082-5","volume":"7","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Lancet HIV. 2020;7(6):e434\u201342.","journal-title":"Lancet HIV"},{"issue":"3","key":"4732_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2105\/AJPH.2019.305490","volume":"110","author":"E Samoff","year":"2020","unstructured":"Samoff E, Mobley V, Hudgins M, Cope AB, Adams ND, Caputo CR, et al. HIV outbreak control with effective access to care and harm reduction in North Carolina, 2017\u20132018. Am J Public Health. 2020;110(3):394\u2013400.","journal-title":"Am J Public Health"},{"issue":"1","key":"4732_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12889-022-12604-3","volume":"22","author":"LM Randall","year":"2022","unstructured":"Randall LM, Dasgupta S, Day J, DeMaria A, Musolino J, John B, et al. An outbreak of HIV infection among people who inject drugs in Northeastern Massachusetts: findings and lessons learned from a medical record review. BMC Public Health. 2022;22(1):257. https:\/\/doi.org\/10.1186\/s12889-022-12604-3.","journal-title":"BMC Public Health"},{"key":"4732_CR17","unstructured":"New York City Department of Health and Mental Health. Overdose continues to rise in NYC as harm reduction programming scales up New York City 2022. https:\/\/www1.nyc.gov\/site\/doh\/about\/press\/pr2022\/overdose-increases-as-harm-reduction-program-scales-up.page. Accessed 15 Jul 2022."},{"issue":"7","key":"4732_CR18","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/j.1360-0443.2004.00693.x","volume":"99","author":"WK Bryant","year":"2004","unstructured":"Bryant WK, Galea S, Tracy M, Markham Piper T, Tardiff KJ, Vlahov D. Overdose deaths attributed to methadone and heroin in New York City, 1990\u20131998. Addiction. 2004;99(7):846\u20134. https:\/\/doi.org\/10.1111\/j.1360-0443.2004.00693.x.","journal-title":"Addiction."},{"issue":"3","key":"4732_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/00952998008993431","volume":"7","author":"DC Des Jarlais","year":"1980","unstructured":"Des Jarlais DC, Uppal GS. Heroin activity in new York City, 1970\u20131978. Am J Drug Alcohol Abuse. 1980;7(3):335\u201346.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"4732_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"D Heckathorn","year":"1997","unstructured":"Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Soc Probl. 1997;44(2):174\u201399.","journal-title":"Soc Probl"},{"issue":"1","key":"4732_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1525\/sp.2002.49.1.11","volume":"49","author":"D Heckathorn","year":"2002","unstructured":"Heckathorn D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11\u201334.","journal-title":"Soc Probl"},{"key":"4732_CR22","unstructured":"R Core Team. R: A language and environment for statistical computing. In: Computing RFfS, editor. Vienna Austria 2021."},{"key":"4732_CR23","doi-asserted-by":"publisher","first-page":"107614","DOI":"10.1016\/j.drugalcdep.2019.107614","volume":"205","author":"E Tuazon","year":"2019","unstructured":"Tuazon E, Kunins HV, Allen B, Paone D. Examining opioid-involved overdose mortality trends prior to Fentanyl: new York City, 2000\u20132015. Drug Alcohol Depend. 2019;205:107614. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107614.","journal-title":"Drug Alcohol Depend"},{"key":"4732_CR24","doi-asserted-by":"publisher","first-page":"109630","DOI":"10.1016\/j.drugalcdep.2022.109630","volume":"240","author":"KR Hochstatter","year":"2022","unstructured":"Hochstatter KR, Terplan M, Mitchell SG, Schwartz RP, Dusek K, Wireman K, et al. Characteristics and correlates of Fentanyl preferences among people with opioid use disorder. Drug Alcohol Depend. 2022;240:109630. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109630. Epub 20220915.","journal-title":"Drug Alcohol Depend"},{"key":"4732_CR25","doi-asserted-by":"publisher","first-page":"107547","DOI":"10.1016\/j.drugalcdep.2019.107547","volume":"204","author":"KB Morales","year":"2019","unstructured":"Morales KB, Park JN, Glick JL, Rouhani S, Green TC, Sherman SG. Preference for drugs containing Fentanyl from a cross-sectional survey of people who use illicit opioids in three united States cities. Drug Alcohol Depend. 2019;204:107547. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107547.","journal-title":"Drug Alcohol Depend"},{"key":"4732_CR26","unstructured":"New York City Department of Health and Mental Hygiene. Unintentional Drug Poisoning (Overdose) Deaths Involving Opioids in New York City 2022 New York City 2023. http:\/\/www.nyc.gov\/html\/doh\/downloads\/pdf\/epi\/datatable66.pdf."},{"issue":"Supplement5","key":"4732_CR27","doi-asserted-by":"publisher","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","volume":"222","author":"SB Lyss","year":"2020","unstructured":"Lyss SB, Buchacz K, McClung RP, Asher A, Oster AM. Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016\u20132019: perspectives on recent experience and lessons learned. J Infect Dis. 2020;222(Supplement5):S239\u201349.","journal-title":"J Infect Dis"},{"key":"4732_CR28","doi-asserted-by":"publisher","unstructured":"Des Jarlais DC, Arasteh K, McKnight C, Feelemyer J, Campbell AN, Tross S, et al. Consistent estimates of very low HIV incidence among people who inject drugs: New York City, 2005\u20132014. Am J Public Health. 2016;106(3):503\u20138. https:\/\/doi.org\/10.2105\/ajph.2015.303019.","DOI":"10.2105\/ajph.2015.303019"},{"key":"4732_CR29","unstructured":"New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report. 2022. New York City: NYCDOHMH, 2023."},{"key":"4732_CR30","unstructured":"New York City Department of Health and Mental Hygiene. HIV Surveillance Annual Report. 2021. New York City: NYCDOHMH, 2022."},{"key":"4732_CR31","doi-asserted-by":"publisher","first-page":"109573","DOI":"10.1016\/j.drugalcdep.2022.109573","volume":"238","author":"DC Des Jarlais","year":"2022","unstructured":"Des Jarlais DC, Bobashev G, Feelemyer J, McKnight C. Modeling HIV transmission among persons who inject drugs (PWID) at the end of the HIV epidemic and during the COVID-19 pandemic. Drug Alcohol Depend. 2022;238:109573.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"4732_CR32","doi-asserted-by":"publisher","first-page":"e64789","DOI":"10.1371\/journal.pone.0064789","volume":"8","author":"B Tempalski","year":"2013","unstructured":"Tempalski B, Pouget ER, Cleland CM, Brady JE, Cooper HL, Hall HI, et al. Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992\u20132007. PLoS ONE. 2013;8(6):e64789. https:\/\/doi.org\/10.1371\/journal.pone.0064789.","journal-title":"PLoS ONE"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04732-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04732-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T16:03:26Z","timestamp":1757693006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04732-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4732"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04732-9","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"12 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the New York University IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Consent for publication was obtained from all participants included in the analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Informed consent was obtained for all participants that were included in the original analysis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}